Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c976 |
|---|---|
| Identifier | NCT05528510 |
| Trial Title | A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Guselkumab Dose 1|DRUG: Guselkumab Dose 2|DRUG: Guselkumab Dose 3|OTHER: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Litchfield Park |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2022-09-13 |
|---|---|
| Primary Completion Date | 2024-04-02 |
| Completion Date | 2028-10-06 |